On the recordJuly 27, 2011
Tell me why we should reauthorize user fees for pharmaceuticals and devices when, in the case of devices, the length of time has gone up since we instituted user fees?
Source
congress.govRichard Burr: “Tell me why we should reauthorize user fees for pharmaceuticals and devices when, in the case of devices, the length of…”
Editor's note · Context
Questioning the need for reauthorizing user fees due to increased approval times.
Share
More from Richard Burr
Apr 25, 2022
He was also the author of the Americans With Disabilities Act, helping improve the lives of millions of Americans with disabilities.
Mar 21, 2022
I urge my colleagues, don't make this mistake. I know there is great pressure to do Build Back Better. But this is not the right bill.
Apr 4, 2022
The faster, more predictable, and more accountable the programs are, the more patients stand to benefit from lifesaving, innovative drugs and devices.
Other voices in this conversation
